Zydus Cadila gets tentative USFDA nod for bladder treatment drug
Zydus Cadila on Tuesday said it has received tentative nod from the US health regulator to market its Mirabegron extended-release tablets. The compan02-04-2019
02-04-2019
Cadila Healthcare Ltd - 532321 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Zydus receives tentative approval from the USFDA for Mirabegron Extended-Release Tablets02-04-2019
CADILA HEALTHCARE LTD. - 532321 - Disclosure of Voting results of Postal Ballot (Regulation 44(3) of SEBI (LODR) Regulations, 2015)
Cadila Healthcare Ltd has informed BSE regarding the details of Voting results of Postal Ballot, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here30-03-2019
CADILA HEALTHCARE LTD. - 532321 - Announcement Of Results
Announcement of Results along with Scrutinizer''s Consolidated Report and the proceedings of the Postal Ballot.30-03-2019
Zydus Cadila gets USFDA nod for drug to treat high blood pressure in lungs
Drug maker Zydus Cadila on Friday said it has received the final approval from the US health regulator to market Ambrisentan tablets, used to treat29-03-2019
CADILA HEALTHCARE LTD. - 532321 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Zydus receives final approval from the USFDA for Ambrisentan Tablets29-03-2019
Cadila Healthcare Ltd - 532321 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Zydus scores with the Day 1 launch of Tadalafil Tablets in the US27-03-2019
CADILA HEALTHCARE LTD. - 532321 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
USFDA Inspection completed at Alidac Pharmaceuticals27-03-2019
Zydus Cadila gets USFDA nod for generic mental disorders drug
Pharmaceutical firm Zydus Cadila on Friday said it has received final approval from US health regulator to market lurasidone hydrochloride tablets u22-03-2019
CADILA HEALTHCARE LTD. - 532321 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Cadila's Pharmaceutical Technology Centre (PTC) successfully completes USFDA inspection22-03-2019